Kestra Medical Techs Analyst Price Targets - Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,710.00+0.95%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Kestra Medical Technologies Ltd

KMTSNASDAQ

Trade with Public

Trade with Public

$26.98

1.214.7%

Last update: Oct 9, 4:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Kestra Medical Techs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Kestra Medical Techs (KMTS).

Price Target Range — 7 Quarters

Analyst Consensus — 7 Analysts

6Buy

1Hold

Consensus RatingOverweight# Analysts7Avg. Consensus PT$28Upside to Avg. PT+2.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	BTIG	Marie Thibault	Maintained	Buy	$32
Sep 2, 2026	BTIG	Marie Thibault	Maintained	Buy	$32
Aug 10, 2026	JP Morgan	Robbie Marcus	Initiate	Overweight	$30
Jul 21, 2026	Oppenheimer	Suraj Kalia	Initiate	Perform	—
Jul 15, 2026	BTIG	Marie Thibault	PT Raise	Buy	$30→$32
Apr 9, 2026	Goldman Sachs	David Roman	PT Cut	Neutral	$22→$17
Apr 7, 2026	BTIG	Marie Thibault	Maintained	Buy	$32
Mar 25, 2026	BTIG	Marie Thibault	Maintained	Buy	$32
Mar 18, 2026	BTIG	Marie Thibault	Maintained	Buy	$32
Dec 15, 2025	Goldman Sachs	David Roman	PT Raise	Neutral	$22→$25
Dec 12, 2025	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$27→$28
Dec 12, 2025	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$27→$30
Nov 18, 2025	BTIG	Marie Thibault	Initiate	Buy	$32
Jul 17, 2025	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$28→$27
Apr 16, 2025	Goldman Sachs	David Roman	PT Cut	Neutral	$24→$23
Mar 31, 2025	Wolfe Research	Mike Polark	Initiate	Outperform	$29
Mar 31, 2025	Wells Fargo	Larry Biegelsen	Initiate	Overweight	$28
Mar 31, 2025	Stifel	Rick Wise	Initiate	Buy	$28
Mar 31, 2025	Goldman Sachs	David Roman	Initiate	Neutral	$24
Mar 31, 2025	Piper Sandler	Matt O'Brien	Initiate	Overweight	$27

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on Kestra Medical Techs, Maintains $32 Price Target

BTIG analyst Marie Thibault reiterates Kestra Medical Techs (NASDAQ:KMTS) with a Buy and maintains $32 price target.

Benzinga Newsdesk

Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Kestra Medical Technologies will report its first earnings Sept. 14, with analysts expecting a $0.62 EPS loss and $29.01M revenue.

Avi Kapoor

PRO
BTIG Reiterates Buy on Kestra Medical Techs, Maintains $32 Price Target

BTIG analyst Marie Thibault reiterates Kestra Medical Techs (NASDAQ:KMTS) with a Buy and maintains $32 price target.

Benzinga Newsdesk

This Guidewire Software Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts changed ratings for GWRE, KMTS, CSQR, and STDN. See coverage details and price targets at Benzinga's analyst ratings page.

Avi Kapoor

PRO
JP Morgan Initiates Coverage On Kestra Medical Techs with Overweight Rating, Announces Price Target of $30

JP Morgan analyst Robbie Marcus initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and announces Price Target of $30.

Benzinga Newsdesk

PRO
Oppenheimer Initiates Coverage On Kestra Medical Techs with Perform Rating

Oppenheimer analyst Suraj Kalia initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Perform rating.

Benzinga Newsdesk